Prof. Dr. Oliver A. Cornely, MD, FACP, FIDSA, FAAM, FECMM
Oliver Cornely established FungiScope® in the year 2003. He is the director and chair of Translational Research at the CECAD Institute of the University of Cologne and scientific director of the Center for Clinical Trials. Clinically, he serves as Infectious Diseases Consultant at the University Hospital of Cologne, Germany.
Prof. Cornely is immediate-past President of the European Confederation of Medical Mycology (ECMM), the roof organization of 28 national mycology societies, and did set up the ECMM Global Guideline Program, ECMM Academy (Fellows program), and ECMM Excellence Center Initiative, designating clinical and microbiological excellence centres after an international audit procedure. He is founder and chair of the Infectious Diseases Scientific Working Group of the European Hematology Association (EHA). Oliver Cornely is a member of the Council of the International Society for Human and Animal Mycology (ISHAM) and serves as Chair of the Infectious Diseases Working Party (AGIHO), a working group of the German Society for Haematology and Oncology (DGHO). He is site spokesman for Cologne for the German Center for Infection Research (DZIF).
He coordinates guidelines on invasive fungal infections and currently collaborates with mycologists in 87 countries on tailoring management guidelines to health care settings throughout the world. He intends to intensify global networking, which he regards as paramount to improve management and care of these mostly rare diseases.
Oliver Cornely published over 600 peer-reviewed articles, books, book chapters, and electronic media; runs the YouTube® channel ID in Motion™, and ranks among the Top 1% most cited researchers. He is a reviewer for numerous medical scientific journals, editorial board member for HemaSphere and for Haematologica, and Editor-in-Chief of Mycoses.
Alexandra Dobrick works at the ZfMK – Centre for Environment, Hygiene and Mycology Cologne GmbH for Lalobaroty Dr. Wisplinghoff GbR in Cologne, Germany and is responsible for isolate management.
Prof. Dr. Khosro Hekmat, MD
Prof. Dr. Khosro Hekmat works at the Department of Cardiothoracic Surgery, University of Cologne, Germany and is the director of the thoracic surgery program (CardioCliniC). One of his main focuses are Infectious diseases of the lung. He is a coordinating physician within the FungiScope® Team and is a part of the quality control team.
Dr. Philipp Köhler, MD, FECMM
Philipp Köhler is a specialist in Internal Medicine, Hematology and Oncology at the University Hospital of Cologne, Germany. He is additionally qualified in emergency and internal intensive care medicine and infectiology (DGI). He is a consultant within the FungiScope® Team and is involved in the validation process as part of the quality control.
Dr. Sibylle Mellinghoff, MD
Sibylle Mellinghoff is a specialist in Internal medicine, Hematology and Oncology at the University Hospital of Cologne, Germany. She is a coordinating physician within the FungiScope® Team and is involved in the validation process as part of the quality control.
Prof. Dr. Carsten Müller, MD
Prof. Dr. Carsten Müller is a specialist in Clinical Pharmacology at the University Hospital of Cologne, Germany and is responsible for the therapeutic drug monitoring (TDM)-Lab.
Laman Rahimli is a research associate and doctoral student at the University Hospital of Cologne, Germany. She has studied medicine in Azerbaijan and is specialized for infection-epidemiology. She is involved in the documentation and validation process as part of the quality control and is engaged in the FungiScope®– Candida project.
Dr. Ertan Sal, MD
Ertan Sal is a specialist in paediatrics, pediatric haematology and oncology. He is also qualified in hematopoietic stem cell transplantation. He is involved in the validation process as part of the quality control.
Dr. Jon Salmanton-García, PhD, FECMM
Jon Salmanton-García is a postdoctoral researcher and project manager in the group of Prof. Dr. Oliver A. Cornely, Department I of Internal Medicine, University Hospital Cologne, Germany. He did his PhD thesis on emerging invasive fungal infections, namely mucormycosis, and extremely rare invasive fungal infections within the FungiScope® Team. He has a special interest in registries and questionnaires, database management, invasive fungal infections and infectious diseases in general.
He is also involved in the IDIM Infectious Diseases in Motion YouTube channel, presenting short summarized videos of recent publications around mycology.
Dr. Birgid Schömig-Markiefka, MD
Birgid Schömig-Markiefka is a coordinating physician within the FungiScope® Team and is involved in histological examination of fungus samples.
Dr. Danila Seidel, PhD, FECMM
Danila Seidel is the scientific lead and coordinator of FungiScope® at the University Hospital of Cologne, Germany. Her main research interests are rare invasive fungal infections, the study of their global distribution and clinical relevance with regard to the increasing number of antifungal drug resistances.
For several years, she has been responsible for establishing new collaborations within the FungiScope® network and beyond. With collaboration partners, she analyzes and publishes relevant results from the FungiScope® database. In 2021, she was awarded the title of Fellow of the European Confederation of Mycology (FECMM).
Multiple national and international epidemiological studies have already been conducted and published together with the partners and active members of the FungiScope®-Registry. Danila Seidel is furthermore involved in the One World – One Guideline initiative for the diagnosis and management of fungal infections.
Dr. Rosanne Sprute, MD
Rosanne Sprute is a physician-scientist at the Department for Hematology, Oncology, and Infectious Diseases of the University Hospital Cologne, Germany. Based on this patient population, her translational research interest focuses on opportunistic infections including invasive fungal disease with rare and emerging fungi. She also has an interest in patients with chronic pulmonary aspergillosis.
She is investigator in phase II and III clinical trials evaluating novel drugs for infectious diseases and is involved in the development of medical guidelines at national and international level. She is a coordinating physician within the FungiScope® Team and is involved in the validation process as part of the quality control.
Dr. Jannik Stemler, MD
Jannik Stemler is a coordinating physician within the FungiScope® Team and is involved in the validation process as part of the quality control. Jannik Stemler has been working on multiple projects in the area of epidemiology of rare invasive fungal infections, in clinical trials with anti-infective medicines, and in clinical observational studies on fungal infections in hematological patients at the University Hospital of Cologne. He is specialized on clinical testing of new anti-infectives, epidemiology of invasive mycoses, and pharmacovigilance of antifungals and new oncological therapies.
His clinical focus is infectious medicine, therapy of hematologic neoplasms, and internal intensive care medicine. He is also an active member in several clinical guideline groups and trans-national research networks. He has assisted international meetings and conferences, also as a speaker, and promoted scientific networking.
Natalia Vasenda, M.Sc.
Natalia Vasenda is the project manager of FungiScope® and responsible for contracting, quality control of the FungiScope® Registry and FungiScope® website administration.
Andrea Will is the data manager of FungiScope® and responsible for the documentation and validation process, quality control and creation of accounts for the FungiScope® online questionaire.
Dr. Hilmar Wisplinghoff, MD
Hilmar Wisplinghoff is a specialist in microbiology, virology and infectious disease epidemiology working at the Laboratory Dr. Wisplinghoff GbR in Cologne, Germany. He is also associated to the Institute for Medical Microbiology, Immunology and Hygiene at the University of Cologne, Germany and is our contact for fungal isolate identification and storage at the Laboratory Dr. Wisplinghoff GbR in Cologne, Germany.